Tricida

Tricida

Pharmaceutical company focused on the development and commercialization of its late-stage investigational product candidate
Menlo Park United States (HQ)

Tricida Company information

Edit
Date
Employees
142 people
Ownership
Market cap
$749m
Net debt
$52m
Firm valuation
€634m (Public information from 2020)
USD20162017201820192020E2021E2022E
Revenues----14m27m137m
% growth-----93 %407 %
EBITDA--(103m)(178m)(246m)(238m)(208m)
% EBITDA margin----(1757 %)(881 %)(152 %)
Profit--(103m)(177m)(253m)(241m)(168m)
% profit margin----(1807 %)(893 %)(123 %)
EV / Revenue-----35.0x6.8x
EV / EBITDA---9.7x-9.1x-2.8x-3.9x-4.5x
  • Edit
DateInvestorsAmountRound
$30mSERIES B
$55mSERIES C
$57.5mSERIES D
$100mDEBT
N/A$22.3m
IPO*
Total Funding€143m

Recent News about Tricida

Edit
LocationEdit
United States, Menlo Park
Are you an employee or an investor of this company?
Add your profile